FDA Policy Battles
Casey Mulligan shares his experience in the oval office, discussing the battle within the administration on whether to bring down drug prices through regulation or deregulation. He highlights the success of deregulation in lowering drug prices and the challenges faced in getting the FDA to approve generics.In this clip
From this podcast
EconTalk
Casey Mulligan on Vaccines, the Pandemic, and the FDA
Related Questions